Marion Merrell Dow
Expanding German presence with proposal to acquire Henning Berlin GmbH for undisclosed terms, MMD announces Nov. 26. Henning's 1991 sales are projected at $ 70 mil. and Merrell Dow Pharma's at $ 55 mil. The acquisition will add 450 associates, including a field force of about 100, to Merrell Dow's German 200 employees, which include 135 field sales personnel. Henning's key products are a line for thyroid disorders and related diagnostic tests, including Carbimazole Henning for hyperthyroidism and L- Thyroxin for hypothyroidism. . . .
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth